Rising prevalence of acute kidney
disorders and associated risk factors such as diabetes continue to
escalate the popularity of continuous renal replacement therapy
(CRRT). Additional factors such as the globally increasing geriatric
population, greater R&D initiatives and technological advancement
in dialysis procedures are expected to further boost the demand for
CRRT over the course of time. CRRT has proven to be quite an
effective dialysis procedure and hence being rapidly adopted by a
number of healthcare organisations. A new study conducted by Future
Market Insights projects that revenue of the global market for
continuous renal replacement therapy is set to increase at an
impressive CAGR of 7.7 % during the forecast period (2017-2027).
Moreover, robust marketing and product innovation from CRRT dialysis
equipment manufacturers are favourably impacting the market’s
revenue growth.
FMI’s report titled “Continuous Renal
Replacement Therapy Market: Global Industry Analysis and Opportunity
Assessment 2017–2027” reveals that in 2016, North America
accounted for the largest revenue share of the global CRRT
market. The presence of an advanced healthcare infrastructure and
widespread awareness about the availability of latest dialysis
treatments is supporting the growth of the CRRT market in North
America. Meanwhile, Asia Pacific excluding Japan (APEJ) is expected
to emerge as the most lucrative market for CRRT over the forecast
period, reflecting a CAGR of 8.8%. Towards the end of 2027, the
region’s market is estimated to surpass a valuation of US$ 333 Mn.
The report mentions that many of the
leading market players are actively focusing on introducing new
technologies as well as upgrading their existing products in order to
expand their market presence. At the same time, some of the bigger
companies are going into strategic alliances to leverage the
opportunities present in regions such as North America and APEJ.
Fresenius Medical Care AG & Co. KGaA,
Baxter International Inc., B. Braun Melsungen AG, Nikkiso Co., Ltd,
NxStage Medical, Inc., Asahi Kasei Corp, NIPRO Corporation, Medica
spa., Toray Medical Co., Ltd, Medtronic plc., Bain Medical Equipment
(Guangzhou) Co. Ltd., INFOMED SA., Medical Components, Inc., Medites
Pharma, S.R.O., Jihua Medical Apparatus & Instruments Co.,
Central Admixture Pharmacy Services Inc., Haidylina for Advanced
Medical Industries, Hemoclean Co. Ltd., FARMASOL Medical Products
Ind. and Trd. Co. are among the top companies that operate in the
global market for continuous renal replacement therapy.
Request to view table of content @
Novelty in dialysis treatment is
facilitating interventional procedures with minimal patient
discomfort. Based on product, the consumables segment is projected to
account for the largest value share of the market during the forecast
period. This segment is gaining traction primarily due to an
expanding pool of patients suffering from acute kidney disease and
increasing demand for dialysis in renal replacement therapy.
By end user, both dialysis centre and
hospitals currently account for sizeable revenue shares of the
market. The rising healthcare spending in the emerging economies is
anticipated to result in the establishment of more hospitals and new
multi-specialty dialysis centres in the near future.
Buy Continuous Renal Replacement Therapy
Market Report @
No comments:
Post a Comment